188 related articles for article (PubMed ID: 33194600)
1. Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
Zhang YY; Yang QS; Qing X; Li BR; Qian J; Wang Y; Ning BT
Front Oncol; 2020; 10():538779. PubMed ID: 33194600
[TBL] [Abstract][Full Text] [Related]
2. [Experience in diagnosis and treatment of asparaginase-associated pancreatitis in children].
Chen Z; Li J
Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):854-8. PubMed ID: 25582474
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of asparaginase-associated pancreatitis in children.
Du X; Liu Z; Jia X; Wen Y; Tang Y; Xu X; Jiang M
Pancreatology; 2022 Sep; 22(6):706-712. PubMed ID: 35718704
[TBL] [Abstract][Full Text] [Related]
4. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
[TBL] [Abstract][Full Text] [Related]
5. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
Buie LW; Moore J; van Deventer H
Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
[TBL] [Abstract][Full Text] [Related]
6. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
[TBL] [Abstract][Full Text] [Related]
7. Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity.
Chen CB; Chang HH; Chou SW; Yang YL; Lu MY; Jou ST; Chen HL; Ni YH; Lin DT; Chang MH; Wu JF
Pediatr Res; 2022 Aug; 92(2):459-465. PubMed ID: 34718353
[TBL] [Abstract][Full Text] [Related]
8. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
Wang J; Jia WG; Yang LH; Kuang WY; Huang LB; Chen HQ; Wang LN; Zhou DH; Liao N
Hematology; 2023 Dec; 28(1):2171723. PubMed ID: 36752506
[TBL] [Abstract][Full Text] [Related]
9. Safety profile of a single pegylated asparaginase (PEG-ASP) dose in remission induction for acute lymphoblastic leukemia (ALL).
Helbig G; Armatys A; Boral K; Kopinska AJ; Wozniczka K; Dworaczek M; Chromik K; Koclega A; Panz-Klapuch M; Wysocka M; Janikowska A
Neoplasma; 2018 Nov; 65(6):993-997. PubMed ID: 29940768
[TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase.
Flores-Calderón J; Exiga-Gonzaléz E; Morán-Villota S; Martín-Trejo J; Yamamoto-Nagano A
J Pediatr Hematol Oncol; 2009 Oct; 31(10):790-3. PubMed ID: 19770681
[TBL] [Abstract][Full Text] [Related]
11. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Abshire TC; Pollock BH; Billett AL; Bradley P; Buchanan GR
Blood; 2000 Sep; 96(5):1709-15. PubMed ID: 10961868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
Oh HJ; Im SA; Lee JW; Chung NG; Cho B
Pediatr Hematol Oncol; 2014 Oct; 31(7):647-55. PubMed ID: 24933500
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of endoscopic retrograde cholangiopancreatography in recurrent pancreatitis of pediatric asparaginase-associated pancreatitis.
Yang KH; Zeng JQ; Ding S; Zhang TA; Wang WY; Zhang JY; Wang L; Xiao J; Gong B; Deng ZH
World J Gastrointest Endosc; 2023 Oct; 15(10):614-622. PubMed ID: 37900113
[TBL] [Abstract][Full Text] [Related]
14. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of asparaginase-associated pancreatitis based on elevated serum elastase-1 levels: Case reports.
Morimoto T; Hirai K; Fukumura A; Takakura H; Koike T; Shimizu T
Biomed Rep; 2013 Jul; 1(4):651-653. PubMed ID: 24649003
[TBL] [Abstract][Full Text] [Related]
16. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K
J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057
[TBL] [Abstract][Full Text] [Related]
17. Association of asparaginase-associated pancreatitis and ULK2 gene polymorphism.
Wang J; Cheng S; Hu L; Huang T; Huang Z; Hu S
Int J Clin Exp Pathol; 2020; 13(3):347-356. PubMed ID: 32269672
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated Pancreatitis.
Mauney EE; Power-Hays A; Flamand Y; Vrooman L; Silverman LB; Grover AS
J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):402-407. PubMed ID: 34694268
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia].
Cooperation Group of Phase II Clinical Trial of PEG-Asp
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312
[TBL] [Abstract][Full Text] [Related]
20. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
